A STUDY OF LAPAROSCOPIC INTRAPERITONEAL ONLAY MESH PLUS REPAIR FOR VENTRAL HERNIA

This study aimed to evaluate the effectiveness and safety of laparoscopic intraperitoneal onlay mesh plus (IPOM plus) repair for ventral hernia. Conducted at a tertiary care hospital between March 2022 and August 2024, it included 50 patients who underwent IPOM plus repair. The research focused on the patients' demographic and clinical characteristics, operative details, outcomes, and complications. Among the 50 patients, most (36%) were between 31 and 40 years old, with a female majority (64%). Primary ventral hernias were more common (70%) compared to incisional hernias (30%). Many patients had signicant co-morbidities, with diabetes (36%) and hypertension (24%) being the most prevalent. The study also noted that most hernias were between 2-5 cm in size. The surgical procedure had a mean operative time of 85.34 minutes, which indicates a reasonable duration for laparoscopic intervention. Only 6% of patients experienced intraoperative complications, showcasing the safety prole of the procedure. Postoperatively, most patients (92%) were discharged within 2-4 days, highlighting the potential for a faster recovery compared to traditional open surgery. However, some postoperative complications were observed. About 18% of patients experienced issues such as subacute intestinal obstruction, port site infections, and seroma formation. Despite these complications, the overall outcomes were favorable, with no mortality reported and a low recurrence rate during the follow-up period. The study concludes that IPOM+ repair is an effective and safe technique for ventral hernia repair. It offers several advantages, including reduced recurrence, faster recovery, and fewer complications compared to traditional open repair methods. These results suggest that IPOM+ is a viable alternative for ventral hernia surgery, particularly for patients seeking minimally invasive options with favorable outcomes.